HK1245659A1 - Cell therapy for the treatment of neurodegeneration - Google Patents

Cell therapy for the treatment of neurodegeneration

Info

Publication number
HK1245659A1
HK1245659A1 HK18105263.9A HK18105263A HK1245659A1 HK 1245659 A1 HK1245659 A1 HK 1245659A1 HK 18105263 A HK18105263 A HK 18105263A HK 1245659 A1 HK1245659 A1 HK 1245659A1
Authority
HK
Hong Kong
Prior art keywords
neurodegeneration
treatment
cell therapy
therapy
cell
Prior art date
Application number
HK18105263.9A
Other languages
Chinese (zh)
Inventor
托馬斯‧N‧蔡斯
佐佐木經世
古賀三奈子
Original Assignee
Ｎｃ醫學研究公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ｎｃ醫學研究公司 filed Critical Ｎｃ醫學研究公司
Priority to HK18105263.9A priority Critical patent/HK1245659A1/en
Publication of HK1245659A1 publication Critical patent/HK1245659A1/en

Links

HK18105263.9A 2018-04-23 2018-04-23 Cell therapy for the treatment of neurodegeneration HK1245659A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HK18105263.9A HK1245659A1 (en) 2018-04-23 2018-04-23 Cell therapy for the treatment of neurodegeneration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HK18105263.9A HK1245659A1 (en) 2018-04-23 2018-04-23 Cell therapy for the treatment of neurodegeneration

Publications (1)

Publication Number Publication Date
HK1245659A1 true HK1245659A1 (en) 2018-08-31

Family

ID=71142841

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18105263.9A HK1245659A1 (en) 2018-04-23 2018-04-23 Cell therapy for the treatment of neurodegeneration

Country Status (1)

Country Link
HK (1) HK1245659A1 (en)

Similar Documents

Publication Publication Date Title
HK1247129A1 (en) Combination therapy for the treatment of cancer
IL267795A (en) Combination therapy for the treatment of cancer
HK1251475A1 (en) Combination therapy for the treatment of cancer
GB201804255D0 (en) Macrophage-based therapy
IL283948A (en) Methods for the treatment of depression
IL280337A (en) Lag-3 combination therapy for the treatment of cancer
ZA202206743B (en) Therapy for the treatment of cancer
IL281845A (en) Combination therapy for the treatment of cancer
GB201900702D0 (en) Therapy
GB201819853D0 (en) Therapy
SG11202101819QA (en) Gene therapy for the treatment of galactosemia
IL284162A (en) Combination therapy for the treatment of cancer
IL280726A (en) Treatment of b cell malignancies
IL266993A (en) Combination therapy for the treatment of cancer
ZA201901578B (en) Combinations including abx196 for the treatment of cancer
IL286000A (en) Esketamine for the treatment of depression
IL281997A (en) Combination therapy for the treatment of uveal melanoma
SG11202101671PA (en) Anti-lmp2 tcr-t cell therapy for the treatment of ebv-associated cancers
SG11202011434SA (en) Methods for the treatment of bladder cancer
HK1245659A1 (en) Cell therapy for the treatment of neurodegeneration
HK1245332A1 (en) Cell therapy for the treatment of neurodegeneration
HK1246145A1 (en) Cell therapy for the treatment of neurodegeneration
IL253642A0 (en) Combination therapy for the treatment of cancer
GB201914848D0 (en) Therapy
GB201913785D0 (en) Therapy